4 days ago

Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors

Larotrectinib led to rapid/durable responses and high disease control rates in children with TRK fusion-position central nervous system cancers.

Comments

CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive

Researchers identify gene signature for high-risk form of T-cell acute lymphoblastic leukemia

If My Dying Daughter Could Face Her Mortality, Why Couldn’t the Rest of Us?

FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

Cell therapy fights lethal childhood brain cancer in Stanford Medicine trial

Increased Surveillance Recommended for Children at Risk for Hematopoietic Malignancy Predisposition

Targeted therapy and radiation synergize in pediatric high-grade glioma

Even 15 Years Later, Childhood Cancer Survivors More Likely to Develop Leukemia